# Lycopene or Green Tea for Men at Risk of Prostate Cancer

> **NCT01105338** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Bristol** · enrollment: 126 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **BEHAVIORAL:** Green tea drink
- **DIETARY_SUPPLEMENT:** green tea capsules
- **OTHER:** Green tea placebo capsules
- **DIETARY_SUPPLEMENT:** Lycopene capsules
- **OTHER:** Lycopene placebo capsules
- **OTHER:** Tomato rich diet

## Key facts

- **NCT ID:** NCT01105338
- **Lead sponsor:** University of Bristol
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2018-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01105338

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01105338, "Lycopene or Green Tea for Men at Risk of Prostate Cancer". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01105338. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*